Abstract:Background: Although observational studies have reported associations of serum C-reactive protein (CRP) with cardiovascular disease (CVD) risk, inconsistent or absent evidences were presented. We aimed to comprehensively estimate the associations of CRP with CVD outcomes in both observational study and mendelian randomization analysis.Methods: Participants free of CVD at baseline in the UK Biobank were included in the analysis. Cox proportional hazards regression was performed to estimate the associations of CRP concentrations with CVD outcomes. Two-sample mendelian randomization were performed to investigate the potential causal associations of CRP with CVDs.Results: In total, 428,253 individuals free of CVD at baseline were included. During a median follow-up year of 7.9 years, 34706 CVD cases were diagnosed. Observational analyses suggested that CRP concentration was significantly associated with an increased risk of a range of CVD outcomes by at least 10%-35%. Notably, the estimates of CRP concentration on CVD outcomes varied, with peripheral vascular disease at the highest risk (HR=1.35, 95% CI: 1.28-1.42), followed by abdominal aortic aneurysm (HR=1.34, 95% CI: 1.24-1.44), aortic aneurysm (HR=1.32, 95% CI: 1.24-1.41) and heart failure (HR=1.31, 95% CI: 1.27-1.35). Compared with those with a CRP <1 mg/L, individuals with a CRP 1 to 3 mg/L had an adjusted HR of 1.16 (95% CI, 1.13 to 1.19), and those with a CRP >3 mg/L had the highest risk of 1.33 (95% CI, 1.29 to 1.37) for total CVD. However, there was no evidence for causal associations between genetically-predicted CRP levels and risk of CVDs.Conclusion: CRP levels were strongly associated with a range of CVD events, especially for peripheral vascular disease, aortic aneurysm diseases and heart failure. However, no causal association was observed for genetically-predicted CRP and CVDs.Funding: This research was supported by the Special Fund for Health Scientific Research in Public Welfare (Grant No. 201502006), the Key Project of Natural Science Funds of China (Grant No. 81230066), and the National Natural Science Foundation of China (Grant Nos. 81872695 and 82204135). The China Postdoctoral Science Foundation supports WMY (Grant Nos. BX2021021 and 2022M710249).Declaration of Interest: All the authors declare no conflicts of interest in the work.Ethical Approval: This study was conducted according to the Declaration of Helsinki. The generic ethical approval was obtained by UK Biobank from the NHS National Research Ethics Service (approval letter dated June 17th 2011, Ref 11/NW/0382). The Northwest England Research Ethics Committee approved the study, and all participants signed written informed consent forms.

Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomisation Study

Positive Association Between High-Sensitivity C-Reactive Protein and Incidence of Type 2 Diabetes Mellitus in Japanese Workers: 6-Year Follow-Up

The Impact of Homocysteine on the Risk of Coronary Artery Diseases in Individuals with Diabetes: a Mendelian Randomization Study

Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study

C-reactive Protein for Predicting Cardiovascular and All-Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis

A Positive Causal Influence of IL-18 Levels on the Risk of T2DM: A Mendelian Randomization Study.

Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach

Postoperative blood salvage and reinfusion in total knee arthroplasty.

A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy

Causal relationship between circulating immune cells and the risk of type 2 diabetes: a Mendelian randomization study

Haplotype analysis on association between C-reactive protein gene and susceptibility to type 2 diabetes mellitus in Chinese Han population

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: an Observational and Mendelian Randomization Study

A multiethnic bidirectional Mendelian randomization study negates causal effects of C-reactive protein concentrations on lung cancer

Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis

Exposing the Causal Effect of Body Mass Index on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study.

Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study

Localization of CYP2D16 in the guinea pig adrenal cortex by immunohistochemistry and in situ hybridization

Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis

Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study

Causal effects of genetically predicted type 2 diabetes mellitus on blood lipid profiles and concentration of particle-size-determined lipoprotein subclasses: A two-sample Mendelian randomization study

Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis